Skip to main content

Biocrates Raises $6.3M to Commercialize High-Content Products

NEW YORK, June 29 (GenomeWeb News) - Biocrates Life Sciences said today that it has closed a €5 million ($6.3 million) private equity investment with MIG Funds of Germany.


The financing will enable Biocrates to commercialize its high-content metabolite analysis platform, application software, and consumable-based products.


The MIG corporations raise venture capital to invest preferentially into selected businesses in Germany and Austria.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.